Please assess the completion status of the following clinical trial:

Trial Title: Antibiotics During Intrauterine Balloon Tamponade Placement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* Able to give consent~* Gestational age \> 24 weeks~* Postpartum~* Placement of an IBT within the last 2 hours with plans for it to remain in situ for at least 2 hours~* Primary obstetrician amenable to proceeding with either method of management during the study period.~Exclusion Criteria:~* Age \< 18 years old~* IBT removed within 2 hours of placement~* Chorioamnionitis~* Insufficient documentation of demographics, delivery outcomes, or peripartum events including postpartum hemorrhage, infectious outcomes

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): The patient will not receive antibiotics as part of the study, though if at any time her provider chooses to administer antibiotics either prophylactically or for treatment she will not prohibited in any way from this or any other treatment as appropriate.
- Antibiotics (Type: EXPERIMENTAL): The patient will receive a 24-hour course of antibiotics. The primary antibiotic of choice will be cefazolin 1 gm iv q8 hours. If the patient has contraindications to the use of cefazolin including cefazolin allergy, hypersensitivity, or severe beta lactam allergy, then clindamycin 900 mg iv q8 hours will be used instead.

Based on this trial design, predict the completion outcome and termination type (if applicable).